{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T07:28:46Z","timestamp":1781249326092,"version":"3.54.1"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ijid.2024.01.016","type":"journal-article","created":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T06:51:26Z","timestamp":1706251886000},"page":"102-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Ending lymphatic filariasis and onchocerciasis in Africa: Reasons for hope"],"prefix":"10.1016","volume":"140","author":[{"given":"Tsitsi","family":"Masiyiwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses John","family":"Bockarie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2024.01.016_sbref0001","series-title":"Reaching the last mile forum 2023","year":"2024"},{"key":"10.1016\/j.ijid.2024.01.016_sbref0002","series-title":"Global partners pledge US$ 777 million to combat neglected tropical diseases","year":"2023"},{"issue":"9747","key":"10.1016\/j.ijid.2024.01.016_bib0003","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(10)60586-7","article-title":"Lymphatic filariasis and onchocerciasis","volume":"376","author":"Taylor","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2024.01.016_bib0004","series-title":"Elimination of human onchocerciasis: progress report, 2022\u20132023","first-page":"572","year":"2023"},{"key":"10.1016\/j.ijid.2024.01.016_sbref0005","series-title":"Scoping the needs and gaps of endemic countries in the onchocerciasis elimination programme: findings report, June 2023","year":"2023"},{"key":"10.1016\/j.ijid.2024.01.016_sbref0006","series-title":"Ending the neglect to attain the Sustainable Development Goals: A road map for neglected tropical diseases 2021\u20132030","year":"2021"},{"issue":"4","key":"10.1016\/j.ijid.2024.01.016_bib0007","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1473-3099(23)00151-2","article-title":"A new key-player for onchocerciasis elimination","volume":"23","author":"Jesudason","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2024.01.016_sbref0008","series-title":"Reaching the last mile","year":"2024"},{"key":"10.1016\/j.ijid.2024.01.016_sbref0009","series-title":"The END Fund celebrates the expansion of the Reaching the last Mile Fund to eliminate River Blindness and Lymphatic Filariasis in Africa","year":"2024"},{"key":"10.1016\/j.ijid.2024.01.016_sbref0010","series-title":"Progress in eliminating onchocerciasis in the WHO Region of the Americas: disruption of ivermectin mass drug administration in the Yanomami focus area due to the COVID-19 pandemic","year":"2021"},{"issue":"3","key":"10.1016\/j.ijid.2024.01.016_bib0011","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1016\/S2214-109X(15)00292-2","article-title":"Reducing the population requiring interventions against lymphatic filariasis in Africa","volume":"4","author":"Bockarie","year":"2016","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ijid.2024.01.016_bib0012","series-title":"Global programme to eliminate lymphatic filariasis: progress report, 2022","first-page":"489","year":"2023"},{"key":"10.1016\/j.ijid.2024.01.016_bib0013","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1146\/annurev.ento.54.110807.090626","article-title":"Role of vector control in the global program to eliminate lymphatic filariasis","volume":"54","author":"Bockarie","year":"2009","journal-title":"Annu Rev Entomol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224000171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224000171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:13:10Z","timestamp":1761120790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971224000171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":13,"alternative-id":["S1201971224000171"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2024.01.016","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ending lymphatic filariasis and onchocerciasis in Africa: Reasons for hope","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2024.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}